This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Betty Diamond, MD; Matthew D. Scharff, MD

JAMA. 1982;248(23):3165-3169.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Problems With Conventional Antisera

The immune response plays an important role in man's resistance to infectious agents and has evolved to protect us from the many pathogens in our environment. The antibodies that are generated in response to foreign substances can also provide effective reagents for diagnosing and treating many diseases. However, since the natural role of such antibodies is to protect us from invading organisms, a major characteristic of the immune response is its heterogeneity, with many different antibodies being made in response to each antigen. This has complicated the use of antibodies as diagnostic reagents and therapeutic tools because most immune sera, whether raised in animals or man, are a mixture of hundreds to thousands of antibodies that differ from each other in their affinity and specificity. They also differ in their ability to carry out effector functions, such as the binding to macrophages, the fixation of complement, . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Medicine, Microbiology and Immunology, and Cell Biology, Albert Einstein College of Medicine, Bronx, NY.

Footnotes
Reprint requests to the Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461 (Dr Scharff).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?